SCHEMBL23098933

SCHEMBL23098933

c1ccc(-c2cc(-c3ccccn3)c3[nH]ccc3n2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 1/20 0.46
▸ CCR1 P32246 3/20 0.46
▸ CCR5 P51681 3/20 0.46
▸ CCR8 P51685 3/20 0.46
▸ KDM4E B2RXH2 7/20 0.45
▸ LMNA P02545 5/20 0.45
▸ METAP1 P53582 5/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ BLM P54132 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ DOHH Q9BU89 1/20 0.45
▸ P4HTM Q9NXG6 1/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ TP53 P04637 2/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ ALPL P05186 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15712028 0.75 PRKCI (0.50) PRKCICCR1CCR5CCR8KDM4E
SCHEMBL23098929 0.72 KDM4E (0.41) PRKCICCR1CCR5CCR8KDM4E
SCHEMBL23098903 0.70 SMN1; SMN2 (0.46) KDM4ELMNAMETAP1HIF1ASMN1; SMN2
SCHEMBL404747 0.70 PRKCI (0.56) PRKCICCR1CCR5CCR8KDM4E
Dipyridyl SCHEMBL2047952 0.70 KDM4E (0.93) CCR1CCR5CCR8KDM4ELMNA
Dipyridyl SCHEMBL30063914 0.70 KDM4E (0.93) CCR1CCR5CCR8KDM4ELMNA
Dipyridyl SCHEMBL27829860 0.68 KDM4E (0.70) PRKCICCR1CCR5CCR8KDM4E
SCHEMBL13133534 0.68 KDM4E (0.70) CCR1CCR5CCR8KDM4ELMNA
SCHEMBL28264205 0.68 PRKCI (0.54) PRKCICCR1CCR5CCR8KDM4E
SCHEMBL29725567 0.68 KDM4E (0.68) PRKCICCR1CCR5CCR8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11731990-B2 Carbazole-based Bodipys for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-08-22 — — US disclosed
US-11731990-B2 Carbazole-based Bodipys for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-08-22 — — US disclosed
EP-3621971-B1 CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-06-23 — — EP disclosed
US-20210079024-A1 CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210079024-A1 CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES CYP1B1, ECI1, FIS1 PRKCI 3354/4885CCR1 817/4885CCR5 1699/4885
US-11731990-B2 Carbazole-based Bodipys for organic electroluminescent devices CYP1B1, ECI1, FIS1 PRKCI 3354/4885CCR1 817/4885CCR5 1699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback